Patricia Carr's most recent trade in Jazz Pharmaceuticals plc was a trade of 1,436 Ordinary Shares done at an average price of $186.8 . Disclosure was reported to the exchange on March 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 186.77 per share. | 05 Mar 2026 | 1,436 | 7,799 (0%) | 0% | 186.8 | 268,205 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 182.94 per share. | 05 Mar 2026 | 1,287 | 6,512 (0%) | 0% | 182.9 | 235,444 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 2,223 | 11,605 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 194.11 per share. | 26 Feb 2026 | 1,253 | 10,352 (0%) | 0% | 194.1 | 243,222 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 190.91 per share. | 26 Feb 2026 | 1,117 | 9,235 (0%) | 0% | 190.9 | 213,243 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 2,370 | 9,382 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2025 | 4,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 171.20 per share. | 05 Dec 2025 | 4,500 | 7,012 (0%) | 0% | 171.2 | 770,405 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 140.67 per share. | 05 Dec 2025 | 4,500 | 11,512 (0%) | 0% | 140.7 | 633,015 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 171.11 per share. | 05 Dec 2025 | 160 | 7,012 (0%) | 0% | 171.1 | 27,378 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2025 | 5,250 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 182.07 per share. | 18 Nov 2025 | 5,250 | 7,012 (0%) | 0% | 182.1 | 955,868 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 136.18 per share. | 18 Nov 2025 | 5,250 | 12,262 (0%) | 0% | 136.2 | 714,945 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 181.67 per share. | 18 Nov 2025 | 69 | 7,012 (0%) | 0% | 181.7 | 12,535 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 138.23 per share. | 07 Mar 2025 | 1,333 | 8,152 (0%) | 0% | 138.2 | 184,261 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 137.81 per share. | 07 Mar 2025 | 1,140 | 7,012 (0%) | 0% | 137.8 | 157,103 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 144.42 per share. | 27 Feb 2025 | 4,500 | 8,237 (0%) | 0% | 144.4 | 649,873 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 4,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 113.10 per share. | 27 Feb 2025 | 4,500 | 12,737 (0%) | 0% | 113.1 | 508,950 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 2,889 | 10,258 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 143.29 per share. | 27 Feb 2025 | 773 | 9,485 (0%) | 0% | 143.3 | 110,767 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 142.43 per share. | 27 Feb 2025 | 497 | 7,369 (0%) | 0% | 142.4 | 70,788 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 142.43 per share. | 27 Feb 2025 | 371 | 7,866 (0%) | 0% | 142.4 | 52,840 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 144.42 per share. | 27 Feb 2025 | 313 | 8,237 (0%) | 0% | 144.4 | 45,202 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 123.36 per share. | 27 Feb 2025 | 313 | 8,550 (0%) | 0% | 123.4 | 38,612 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 313 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 1,641 | 8,237 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 122.49 per share. | 02 Dec 2024 | 53 | 6,596 (0%) | 0% | 122.5 | 6,492 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 108.82 per share. | 07 Jun 2024 | 163 | 6,596 (0%) | 0% | 108.8 | 17,738 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 116.98 per share. | 06 Mar 2024 | 1,768 | 6,596 (0%) | 0% | 117.0 | 206,821 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 120.85 per share. | 06 Mar 2024 | 1,236 | 9,064 (0%) | 0% | 120.9 | 149,371 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 117.51 per share. | 06 Mar 2024 | 700 | 8,364 (0%) | 0% | 117.5 | 82,257 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,987 | 10,300 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 1,327 | 7,363 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Carr Patricia | SVP, Chief Accounting Officer | 31 Dec 2023 | 50 | 5,986 (0%) | 0% | 121.4 | 6,070 | Ordinary Shares | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 143.47 per share. | 29 Aug 2023 | 142 | 5,986 (0%) | 0% | 143.5 | 20,373 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 138.16 per share. | 14 Aug 2023 | 158 | 6,128 (0%) | 0% | 138.2 | 21,829 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 127.91 per share. | 07 Jun 2023 | 126 | 6,286 (0%) | 0% | 127.9 | 16,117 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 133.22 per share. | 15 Mar 2023 | 1,023 | 6,286 (0%) | 0% | 133.2 | 136,284 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 2,523 | 8,457 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 140.76 per share. | 03 Mar 2023 | 1,148 | 7,309 (0%) | 0% | 140.8 | 161,594 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 152.06 per share. | 05 Dec 2022 | 63 | 5,934 (0%) | 0% | 152.1 | 9,580 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 113.10 per share. | 15 Aug 2022 | 2,000 | 7,934 (0%) | 0% | 113.1 | 226,200 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 2,000 | 4,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 160.29 per share. | 15 Aug 2022 | 2,000 | 5,934 (0%) | 0% | 160.3 | 320,580 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 156.86 per share. | 15 Aug 2022 | 142 | 5,934 (0%) | 0% | 156.9 | 22,274 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 152.32 per share. | 08 Aug 2022 | 158 | 6,076 (0%) | 0% | 152.3 | 24,067 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 150.26 per share. | 02 Jun 2022 | 131 | 6,234 (0%) | 0% | 150.3 | 19,684 | Ordinary Shares |
| Jazz Pharma PLC | Patricia Carr | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 2,488 | 8,296 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharma PLC | Patricia Carr | SVP, Finance & PAO | Sale of securities on an exchange or to another person at price $ 147.96 per share. | 06 Aug 2021 | 157 | 6,035 (0%) | 0% | 148.0 | 23,230 | Ordinary Shares |